The interaction properties of costimulatory molecules revisited.
暂无分享,去创建一个
Andrea Iaboni | Simon J Davis | David I Stuart | Björn Walse | D. Stuart | S. Davis | R. Gilbert | P. A. van der Merwe | A. Iaboni | P Anton van der Merwe | B. Walse | Alison V Collins | Douglas W Brodie | Robert J C Gilbert | Raquel Manso-Sancho | A. V. Collins | D. Brodie | David I. Stuart | R. Manso-Sancho | S. Davis | A. Collins | Andrea Iaboni
[1] G. I. Bell. Models for the specific adhesion of cells to cells. , 1978, Science.
[2] C. Thompson,et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.
[3] D. Mason,et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. , 1994, Biochemistry.
[4] M. Jenkins. The ups and downs of T cell costimulation. , 1994, Immunity.
[5] P. Linsley,et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.
[6] P. Anton van der Merwe,et al. Topology of the CD2–CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells , 1995, Current Biology.
[7] Laurie H Glimcher,et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.
[8] P. Linsley,et al. Binding Stoichiometry of the Cytotoxic T Lymphocyte-associated Molecule-4 (CTLA-4) , 1995, The Journal of Biological Chemistry.
[9] R. Karr,et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.
[10] J. Bluestone,et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.
[11] H. Griesser,et al. Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.
[12] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[13] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[14] T. Mak,et al. Regulation of T Cell Receptor Signaling by Tyrosine Phosphatase SYP Association with CTLA-4 , 1996, Science.
[15] P. Linsley,et al. Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions* , 1996, The Journal of Biological Chemistry.
[16] A. Weiss,et al. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites , 1997, Molecular and cellular biology.
[17] P. Linsley,et al. CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics , 1997, The Journal of experimental medicine.
[18] E. Simpson,et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.
[19] J. Bluestone,et al. Molecular basis of T cell inactivation by CTLA-4. , 1998, Science.
[20] M. Davis,et al. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.
[21] S. Ikemizu,et al. CD2 and the nature of protein interactions mediating cell‐cell recognition , 1998, Immunological reviews.
[22] T. Mak,et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. , 1999, Journal of immunology.
[23] Andreas Hutloff,et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.
[24] B K Jakobsen,et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.
[25] J. Young,et al. A chicken homologue of the co-stimulating molecule CD80 which binds to mammalian CTLA-4 , 1999, Immunogenetics.
[26] A. Sharpe,et al. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. , 1999, Journal of immunology.
[27] A. Lanzavecchia,et al. T lymphocyte costimulation mediated by reorganization of membrane microdomains. , 1999, Science.
[28] J. Mizuguchi,et al. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.
[29] A. Sharpe,et al. B7-1 or B7-2 Is Required to Produce the Lymphoproliferative Phenotype in Mice Lacking Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) , 1999, The Journal of experimental medicine.
[30] A. Sharpe,et al. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. , 1999, Journal of immunology.
[31] D I Stuart,et al. Structure and dimerization of a soluble form of B7-1. , 2000, Immunity.
[32] D. Mueller. T cells: A proliferation of costimulatory molecules , 2000, Current Biology.
[33] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[34] Fiona Powrie,et al. Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.
[35] P. Tipping,et al. B7.1 and B7.2 co‐stimulatory molecules regulate crescentic glomerulonephritis , 2000, European journal of immunology.
[36] S. Davis,et al. LICOS, a primordial costimulatory ligand? , 2000, Current Biology.
[37] C. Thompson,et al. Structural Analysis of CTLA-4 Function In Vivo1 , 2000, The Journal of Immunology.
[38] T. Hofmann,et al. Tyrosine-phosphorylated Vav1 as a Point of Integration for T-cell Receptor- and CD28-mediated Activation of JNK, p38, and Interleukin-2 Transcription* 210 , 2000, The Journal of Biological Chemistry.
[39] Andrea Iaboni,et al. The immunological synapse and CD28-CD80 interactions , 2001, Nature Immunology.
[40] A. Fedorov,et al. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex , 2001, Nature.
[41] J. Bluestone,et al. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.
[42] Yan Zhang,et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses , 2001, Nature.
[43] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[44] Mary Collins,et al. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. , 2002, Annual review of immunology.